معرفی
Eleftheria Zeggini is a Professor at the Technical University Munich (TUM) School of Medicine and Health and the founding Director of the Institute of Translational Genomics at Helmholtz Munich, Germany. Her research focuses on leveraging big biomedical data to translate genomics insights into mechanisms of disease development and progression, advancing precision medicine.
- Education
- PhD in Genetic dissection of the MHC in juvenile oligoarthritis (University of Manchester, UK, 2003)
- BSc (Hons) in Biochemistry (UMIST, UK, 1999)
Her research spans translational genomics, cardiometabolic diseases, type 2 diabetes, osteoarthritis, and digital health. She has secured significant grants from organizations like the German Research Foundation (DFG), Helmholtz Munich, Wellcome Trust, and European Research Council (ERC). Her work integrates multi-omics approaches, single-cell technologies, and population genetics to address complex diseases.
Notable scientific awards include ERC Starting Grant, EMBO membership, ELLIS Fellowship, and multiple Web of Science Highly Cited Researcher recognitions. She has held leadership roles in academic advisory boards across Europe and Africa.
